Chlormadinone acetate suppresses prostaglandin biosynthesis in human endometrial explants
详细信息    查看全文
文摘
| Figures/TablesFigures/Tables | ReferencesReferences

Objective

To elucidate the mode of action of chlormadinone acetate (CMA) in reducing dysmenorrheic pain by studying the effects of CMA and dexamethasone (DEX) on messenger RNA (mRNA) abundance of cyclo-oxygenase-2 (COX-2), annexin-1 (ANXA1), glucocorticoid receptor (GR), progesterone receptor (PR), and concentrations of prostaglandin F2¦Á (PGF2¦Á) and leukotrienes B4 (LTB4) and C4 (LTC4) in human endometrial explants.

Design

Ex?vivo study.

Setting

University hospital.

Patient(s)

Fifteen premenopausal patients undergoing surgery for benign gynecologic disorders.

Intervention(s)

Endometrial explants were obtained by aspiration curettage and stimulated ex?vivo with interleukin-1¦Â before exposure to CMA or DEX; mRNA levels were determined via reverse transcription-quantitative real-time polymerase chain reaction, and concentrations of arachidonic acid metabolites by enzyme immunoassays.

Main Outcome Measure(s)

Messenger RNA levels of COX-2, ANXA1, PR, and GR; concentrations of PGF2¦Á, LTB4, and LTC4 in endometrial explants treated with CMA or DEX.

Result(s)

In IL-1¦Â-treated explants COX-2 mRNA and PGF2¦Á, concentrations were significantly down-regulated by CMA but not by DEX. Chlormadinone acetate did not affect mRNA abundance of ANXA1, PR, and GR.

Conclusion(s)

Our data suggest that CMA is a suppressor of COX-2 expression. Comparison with DEX revealed that progestin-specific activity of CMA may mainly be responsible for suppression of prostaglandin biosynthesis in human endometrium.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700